tiprankstipranks
Trending News
More News >
Noile-Immune Biotech Inc. (JP:4893)
:4893
Japanese Market

Noile-Immune Biotech Inc. (4893) Income Statement

Compare
0 Followers

Noile-Immune Biotech Inc. Income Statement

Last quarter (Q2 2025), Noile-Immune Biotech Inc.'s total revenue was ¥2.00M, an increase of Infinity% from the same quarter last year. In Q2, Noile-Immune Biotech Inc.'s net income was ¥-171.00M. See Noile-Immune Biotech Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 5.00M¥ 7.59M¥ 316.82M¥ 625.78M¥ 100.73M
Gross Profit
¥ 5.00M¥ 7.39M¥ 314.56M¥ 618.71M¥ 77.83M
Operating Expenses
¥ 802.25M¥ 1.08B¥ 1.09B¥ 725.05M¥ 845.34M
Depreciation and Amortization
¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
EBITDA
¥ -797.25M¥ -1.07B¥ -775.39M¥ -106.34M¥ -767.51M
Operating Income
¥ -797.25M¥ -1.07B¥ -775.39M¥ -106.34M¥ -767.51M
Other Income/Expenses
¥ 6.14M¥ 107.15M¥ -352.20M¥ -277.86M¥ -25.10M
Pretax Income
¥ -791.12M¥ -962.03M¥ -1.13B¥ -384.20M¥ -792.62M
Net Income
¥ -793.54M¥ -964.46M¥ -1.13B¥ -386.62M¥ -795.03M
Per Share Metrics
Basic EPS
¥ -18.33¥ -22.26¥ -27.25¥ -9.87¥ -19.33
Diluted EPS
¥ -18.33¥ -22.26¥ -27.25¥ -9.87¥ -19.33
Weighted Average Shares Outstanding
43.30M 43.30M 41.47M 39.17M 41.12M
Weighted Average Shares Outstanding (Diluted)
43.30M 43.30M 41.47M 39.17M 41.12M
Currency in JPY

Noile-Immune Biotech Inc. Earnings and Revenue History